Impact of progesterone on cytokine-stimulated nuclear factor-kappaB signaling in HeLa cells

References

• Allport V C, Pieber D, Slater D M, Newton R, White J O, Bennett P R. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the ‘functional progesterone withdrawal’. Mol Hum Reprod 2001; 7: 581–586
   PubMed Web of Science ®Google Scholar
• Keelan J A, Blumenstein M, Helliwell R J, Sato T A, Marvin K W, Mitchell M D. Cytokines, prostaglandins and parturition—a review. Placenta 2003; 24: S33–S46
   PubMed Web of Science ®Google Scholar
• Elliott C L, Allport V C, Loudon J A, Wu G D, Bennett P R. Nuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol Hum Reprod 2001; 7: 787–790
   PubMed Web of Science ®Google Scholar
• Kelly R W. Pregnancy maintenance and parturition: The role of prostaglandin in manipulating the immune and inflammatory response. Endocr Rev 1994; 15: 684–706
   PubMed Web of Science ®Google Scholar
• Ito A, Imada K, Sato T, Kubo T, Matsushima K, Mori Y. Suppression of interleukin 8 production by progesterone in rabbit uterine cervix. Biochem J 1994; 301: 183–186
   PubMedGoogle Scholar
• Gu Z, Cain L, Werrbach-Perez K, Perez-Polo J R. Differential alterations of NF-kappaB to oxidative stress in primary basal forebrain cultures. Int J Devel Neurosci 2000; 18: 185–192
   Google Scholar
• Meiss P J, Klebanoff M, Thom E, Dombrowski M P, Sibai B, Moawad A H, Spong C Y, Hauth J C, Miodovnik M, Varner M W, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379–2385
   Google Scholar
• da Fonseca E B, Bittar R E, Carvalho M H, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419–424
   PubMed Web of Science ®Google Scholar
• Ghosh S, May M J, Kopp E B. NF-κB and Rel proteins: Evolutionary conserved mediators of immune responses. Ann Rev Immunol 1998; 16: 225–260
   PubMed Web of Science ®Google Scholar
• Urban M B, Schreck R, Baeuerle P A. NF-kappaB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J 1991; 10: 1817–1825
   PubMed Web of Science ®Google Scholar
• Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002; 109: S81–S96
   PubMed Web of Science ®Google Scholar
• Tran K, Merika M, Thanos D. Distinct functional properties of IkappaB alpha and IkappaB beta. Mol Cell Biol 1997; 17: 5386–5399
   PubMedGoogle Scholar
• Begg A A, Baldwin A S, Jr. The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev 1993; 7: 2064–2070
   Google Scholar
• Alcorn J L, Mendelson C R. Trafficking of surfactant protein A in fetal rabbit lung in organ culture. Am J Physiol 1993; 264: L27–L35
   Google Scholar
• Kurokouchi K, Kambe F, Kikumori T, Sakai T, Sarkar D, Ishiguro N, Iwata H, Seo H. Effects of glucocorticoids on tumor necrosis factor α-dependent activation of nuclear factor κB and expression of the intercellular adhesion molecule 1 gene expression in osteoblast-like ROS17/2.8 cells. J Bone Miner Res 2000; 15: 1707–1715
   Google Scholar
• Auphan N, DiDonato J A, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 1995; 270: 286–290
   PubMed Web of Science ®Google Scholar
• Wissink S, van Heerde E C, van der Burg B, van der Saag P T. A dual mechanism mediates repression of NF-κB activity by glucocorticoids. Mol Endocrinol 1998; 12: 355–363
   PubMed Web of Science ®Google Scholar
• Mitchell M D, Romero R J, Avila C, Foster J T, Edwin S S. Prostaglandin production by amnion and decidual cells in response to bacterial products. Prostaglandins Leukot Essent Fatty Acids 1991; 42: 167–169
   PubMed Web of Science ®Google Scholar
• Romero R, Parvizi S T, Oyarzun E, Mazor M, Wu Y K, Avila C, Athanassiadis A P, Mitchell M D. Amniotic fluid interleukin-1 in spontaneous labor at term. J Reprod Med 1990; 35: 235–238
   PubMed Web of Science ®Google Scholar
• Bertelsen M, Sanfridson A. Inflammatory pathway analysis using a high content screening platform. Assay Drug Dev Technol 2005; 3: 261–271
   PubMed Web of Science ®Google Scholar
• Bamberger C M, Else T, Bamberger A M, Beil F U, Schulte H M. Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes. J Clin Endocrinol Metab 1999; 84: 4055–4061
   PubMedGoogle Scholar
• Allport V C, Slater D M, Newton R, Bennett P R. NF-κB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod 2000; 6: 561–565
   PubMedGoogle Scholar
• Pettus E H, Wright D W, Stein D G, Hoffman S W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Research 2005; 1049: 112–119
   PubMed Web of Science ®Google Scholar
• Kalkhoven E, Wissink S, van der Saag P T, van der Burg B. Negative interaction between the RelA(p65) subunit of NF-κB and the progesterone receptor. J Biol Chem 1996; 271: 6217–6224
   PubMed Web of Science ®Google Scholar
• Bergmann M W, Staples K J, Barnes P J, Newton R. Nuclear factor-κB does not mediate the inhibitory effects of dexamethasone on granulocyte-macrophage colony-stimulating factor expression. Immunology 2004; 111: 430–434
   Google Scholar
• Elovitz M A, Mrinalini C. Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?. Am J Obstet Gynecol 2005; 193: 1149–1155
   PubMed Web of Science ®Google Scholar
• Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M. Bacterial lipopolysaccharide and IFN-γ induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: Role of NF-κB activation. J Immunol 2001; 166: 2018–2024
   PubMed Web of Science ®Google Scholar